Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SANCDB: an update on South African natural compounds and their readily available analogs
Bakary N’tji Diallo, Michael Glenister, Thommas M. Musyoka, et al.
Journal of Cheminformatics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach
Abdul Rashid Issahaku, Elliasu Y. Salifu, Clement Agoni, et al.
ChemistrySelect (2023) Vol. 8, Iss. 24
Closed Access | Times Cited: 35
Design and Development of Novel Nutraceuticals: Current Trends and Methodologies
Thalia Tsiaka, Eftichia Kritsi, Konstantinos Tsiantas, et al.
Nutraceuticals (2022) Vol. 2, Iss. 2, pp. 71-90
Open Access | Times Cited: 28
Learning About Allosteric Drugs and Ways to Design Them
Zhen Wah Tan, Wei-Ven Tee, Igor N. Berezovsky
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167692-167692
Closed Access | Times Cited: 26
Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science
Ifra Saifi, Basharat Ahmad Bhat, Syed Suhail Hamdani, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6523-6541
Closed Access | Times Cited: 11
A critical assessment of bioactive compounds databases
Daniela Quadros de Azevedo, Beatriz Mattos Campioni, Felipe Augusto Pedroz Lima, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 10, pp. 1029-1051
Closed Access | Times Cited: 4
An appraisal of the South African antibacterial plants and their computational bioprospection for putative leads against Staphylococcus aureus penicillin-binding protein 2a and beta-lactamase
Gideon Ampoma Gyebi, Saheed Sabiu
South African Journal of Botany (2025) Vol. 180, pp. 553-578
Open Access
Medicinal Phytocompounds as Potential Inhibitors of p300-HIF1α Interaction: A Structure-Based Screening and Molecular Dynamics Simulation Study
Muhammad Suleman, Abrar Mohammad Sayaf, Saboor Aftab, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 602-602
Open Access
Allostery and Missense Mutations as Intermittently Linked Promising Aspects of Modern Computational Drug Discovery
Özlem Taştan Bishop, Thommas M. Musyoka, Victor Barozi
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167610-167610
Open Access | Times Cited: 17
Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds
Abdul Rashid Issahaku, Samukelisiwe Minenhle Mncube, Clement Agoni, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 4
Closed Access | Times Cited: 9
Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 Mpro and its evolutionary mutations as a case study
Olivier Sheik Amamuddy, Rita Afriyie Boateng, Victor Barozi, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 6431-6455
Open Access | Times Cited: 23
Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective
Cyril T. Namba-Nzanguim, Gemma Turón, Conrad V. Simoben, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 12
Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
Abdulrahim R. Hakami
Biology (2022) Vol. 11, Iss. 2, pp. 258-258
Open Access | Times Cited: 10
Discovery of Isojacareubin as a covalent inhibitor of SARS‐CoV‐2 main protease using structural and experimental approaches
Abbas Khan, Heng Wang, Kashif Imran, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 6
Investigating the role of Sterol C24-Methyl transferase mutation on drug resistance in leishmaniasis and identifying potential inhibitors
Huma Khan, Muhammad Waqas, Beenish Khurshid, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10374-10387
Open Access | Times Cited: 5
Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway
Joanna Panecka-Hofman, Ina Poehner, Rebecca C. Wade
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 9, pp. 1029-1045
Open Access | Times Cited: 8
Identification of Drug Targets and Their Inhibitors in Yersinia pestis Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation Approaches
Hamid Ali, Abdus Samad, Amar Ajmal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1124-1124
Open Access | Times Cited: 4
Overview and limitations of database in global traditional medicines: A narrative review
Xiaolan Li, Jianqing Zhang, Xuanjing Shen, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
Anti-inflammatory Activity of Two Antitussive Plants for Children: Sericanthe chevalieri and Ceiba pentandra
Cheickna Cissé, Mamadou Abdoulaye Konaré, Mariam Samaké, et al.
International Journal Of Pharmaceutical Research And Allied Sciences (2024) Vol. 13, Iss. 4, pp. 19-28
Closed Access | Times Cited: 1
Latin American Natural Product Database (LANaPDB): An Update
Alejandro Gómez‐García, Daniel A. Acuña Jiménez, William J. Zamora, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8495-8509
Open Access | Times Cited: 1
Unveiling the reactivity of truxillic and truxinic acids (TXAs): deprotonation, anion…H–O, cation…O and cation…$${\varvec{\pi}}$$ interactions in TXA0…Y+ and TXA0…Z− complexes (Y = Li, Na, K; Z = F, Cl, Br)
Bienfait Kabuyaya Isamura, Issofa Patouossa, Jules Tshishimbi Muya, et al.
Structural Chemistry (2022) Vol. 34, Iss. 1, pp. 97-112
Closed Access | Times Cited: 6
In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria
Hani Mohammed Ali
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 10, pp. 103424-103424
Open Access | Times Cited: 6
Natural Perylenequinone Compounds as Potent Inhibitors of Schistosoma mansoni Glutathione S-Transferase
Benson Otarigho, Mofolusho O. Falade
Life (2023) Vol. 13, Iss. 10, pp. 1957-1957
Open Access | Times Cited: 3
Ultra-Large-Scale Screening of Natural Compounds and Free Energy Calculations Revealed Potential Inhibitors for the Receptor-Binding Domain (RBD) of SARS-CoV-2
Lisha Guo, Faryar Zafar, Nawal Moeen, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7317-7317
Open Access | Times Cited: 5
Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshop
Fidele Ntie‐Kang, Kiran K. Telukunta, Serge A. T. Fobofou, et al.
Journal of Cheminformatics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches
Aqel Albutti
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 112-112
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top